[ET Net News Agency, 14 June 2024] ASCENTAGE-B (06855) rose 10.6% to HK$22.95, breaking
above the 250-D SMA of HK$22.633.
It hits an intra-day high of HK$22.95, hitting an 1-month high, and an intra-day low of
HK$21.3. The total shares traded was 1.85 million, with a value of HK$40.97m. The active
buy/sell ratio is 70:30, with net buying turnover of HK$14.85m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$765,324, with volume weighted
average price of HK$22.485. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$4.41m, with volume weighted average price of HK$22.271.
The stock has risen a combined 18.7% over the past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 22.950 % Chg +10.60%
High 22.950 Low 21.300
Shares Tr 1.85m Turnover 40.97m
10-D SMA 19.778 %H.V 64.016
20-D SMA 19.369 VWAP 22.196
50-D SMA 18.585 RSI14 67.151
----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
70:30, with net buying turnover of HK$14.85m, rising a combined 18.7% over the past 2
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ASCENTAGE-B (06855) 22.95 +10.60
GENSCRIPT BIO (01548) 9.17 -3.37
INNOVENT BIO (01801) 37.85 +4.41
EVEREST MED-B (01952) 19.96 -0.20
WUXI BIO (02269) 11.94 -2.77
WUXI APPTEC (02359) 34.00 -3.95
BEIGENE (06160) 98.60 -0.80
CANSINOBIO (06185) 22.45 -0.88
ZAI LAB (09688) 15.20 -4.16
AKESO (09926) 39.85 -0.62
---------------------------------------------
(ed)